# DANA Inc: Form 10-K for the period ended Dec 31, 2017

- Company: [DANA Inc](/companies/dan.md) (CIK 26780)
- Form: 10-K
- Filed: 2018-02-14
- Accepted by EDGAR: Feb 14, 2018, 11:25 ET
- Period: 2017-12-31
- Accession: 0000026780-18-000004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/26780/000002678018000004/dan-20171231x10k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/26780/000002678018000004/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2017-10-01 to 2017-12-31 | $254.0m | us-gaap:GrossProfit |
| Research and development | 12 months, 2017-01-01 to 2017-12-31 | $102.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2017-01-01 to 2017-12-31 | $511.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2017-01-01 to 2017-12-31 | $490.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2017-01-01 to 2017-12-31 | $102.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2017-01-01 to 2017-12-31 | $283.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-10-01 to 2017-12-31 | −$104.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months, 2017-01-01 to 2017-12-31 | $111.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-10-01 to 2017-12-31 | −$0.74 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months, 2017-01-01 to 2017-12-31 | $0.71 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-10-01 to 2017-12-31 | −$0.74 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months, 2017-01-01 to 2017-12-31 | $0.72 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2017-01-01 to 2017-12-31 | 146,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2017-01-01 to 2017-12-31 | $554.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2017-01-01 to 2017-12-31 | $393.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months, 2017-01-01 to 2017-12-31 | $35.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2017-12-31 | $603.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-12-31 | $2.88bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-12-31 | $5.64bn | us-gaap:Assets |
| Current liabilities | at 2017-12-31 | $1.70bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-12-31 | $4.48bn | us-gaap:Liabilities |
| Current portion of debt | at 2017-12-31 | $40.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2017-12-31 | $1.01bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/26780/000002678018000004/dan-20171231x10k.htm

Filed Feb 14, 2018.
Source: SEC EDGAR, the filing index for accession 0000026780-18-000004. Last ingested by Listed: Nov 5, 2026, 19:05 ET. No prices; not investment advice.
